Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
A Chlamydia culture, identified by CPT® Code 87110, is a laboratory procedure that involves the cultivation of Chlamydia bacteria from a tissue or cell sample obtained from various anatomical sites. Chlamydia refers to a genus of bacteria, with Chlamydia trachomatis being the most notable species due to its role in sexually transmitted infections (STIs). This particular infection is often asymptomatic, especially in women, which can lead to severe complications such as pelvic inflammatory disease and infertility if left untreated. In men, while symptoms such as burning and itching during urination may occur, the risk of long-term reproductive damage is significantly lower. The procedure entails collecting specimens from multiple potential sources, including the cervix, urethra, rectum, eye, nose, or throat. The collection process involves the careful removal of excess mucus or secretions from the infected area using a swab, followed by the acquisition of the specimen itself with a second swab, ensuring that an adequate number of columnar epithelial cells are collected for accurate culture results. The collected swabs are then placed in a specialized viral chlamydial transport medium to preserve the viability of the bacteria. Subsequently, the specimens are inoculated onto tissue culture cells that are treated with trachomatis-specific antibodies and incubated to promote bacterial growth. Finally, immunofluorescence techniques are employed to detect the presence of Chlamydia, confirming whether the patient is infected.
© Copyright 2026 Coding Ahead. All rights reserved.
The Chlamydia culture is indicated for the diagnosis of infections caused by Chlamydia trachomatis. This procedure is particularly relevant in the following scenarios:
The procedure for obtaining a Chlamydia culture involves several critical steps to ensure accurate results:
Post-procedure care for patients undergoing a Chlamydia culture typically involves providing them with information regarding the timing of results and any necessary follow-up actions. Patients may be advised to refrain from sexual activity until they receive their results to prevent potential transmission of the infection. If a Chlamydia infection is confirmed, appropriate treatment options will be discussed, and follow-up testing may be scheduled to ensure the infection has been effectively treated. Additionally, patients should be informed about the importance of notifying sexual partners to facilitate testing and treatment, thereby reducing the risk of reinfection and further spread of the disease.
| Short Descr | CHLAMYDIA CULTURE | Medium Descr | CULTURE CHLAMYDIA ANY SOURCE | Long Descr | Culture, chlamydia, any source | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 2 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | GP | Services delivered under an outpatient physical therapy plan of care | GW | Service not related to the hospice patient's terminal condition | GZ | Item or service expected to be denied as not reasonable and necessary | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2001-01-01 | Changed | Code description changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.